What if AI could help us discover new medicines faster, more accurately, and with greater impact for patients?

In this episode of AI at Work, I speak with Dr. Chris Austin, Head of Research Technologies at GSK, to explore how artificial intelligence is changing the way new treatments are developed. Chris brings a unique perspective shaped by decades of experience across academia, biotech, government, and now big pharma. His mission at GSK is clear: to bring science, technology, and talent together to radically improve human health.

We unpack how AI, combined with massive clinical and genetic datasets, is enabling GSK to target disease with unprecedented precision. From identifying the right molecular pathways to simulating clinical trials using digital twins, Chris walks us through how technology is helping reduce development timelines and increase the chances of success. He shares powerful examples including a promising asthma treatment that moved from first-in-human testing to Phase 3 trials across four diseases in record time.

We also explore how GSK uses AI to improve patient selection in clinical trials, design oligonucleotide-based therapies for hard-to-treat conditions like hepatitis B, and incorporate generative AI into everything from drug design to safety prediction. According to Chris, the key isn't just having better algorithms. It's about generating the right data, at scale, to make those algorithms meaningful.

If you're curious about how AI is being applied to some of the most complex problems in healthcare, this episode offers a rare inside look. Chris also reflects on his journey from medicine to data science, and why this is the most exciting time he’s seen in drug development.

How do you transform a century-old creative institution into a future-ready force without losing sight of its roots?

In this episode of AI at Work, we spotlight Dr. Joyce Brown, President of the Fashion Institute of Technology (FIT), who has spent 26 years leading a quiet revolution in fashion education. As the first woman and first African American to hold the role, Dr. Brown has reimagined what it means to prepare students for creative careers in a digital world.

She shares how, when she took the helm in 1998, FIT was operating with outdated systems and a siloed approach to education. Through strategic planning, bold hiring decisions, and a commitment to change, she reshaped FIT into a collaborative, interdisciplinary, and forward-looking institution.

Under her leadership, FIT quadrupled its use of technology in teaching and launched the DTech Lab, a hands-on innovation hub where students work directly with brands like Netflix, Adidas, Girl Scouts, and Tommy Hilfiger to solve real challenges using emerging tech like AI and advanced materials.

This episode also explores how FIT is fostering a new wave of sustainable design. Students are using kombucha, mycelium, and pineapple fibers to rethink fashion from the ground up, while also cultivating a natural dye garden on campus. We unpack how the school integrates innovation, science, and sustainability without losing the soul of design.

Dr. Brown reflects on how FIT has responded to social and global shifts, from the pandemic to social justice movements, and how students are using creative work to make sense of the world. Her insights offer a compelling look at what education can achieve when it embraces experimentation, diverse voices, and emerging technologies.

Whether you're in fashion, tech, education, or simply interested in how institutions evolve, this conversation offers a masterclass in visionary leadership and what it takes to truly modernize without losing meaning.

How are you preparing your team or organization for a future shaped by creativity, technology, and purpose? Join the discussion.

What if the limitations of search engines and conventional AI tools are holding back your ability to truly understand the world? In this episode of AI at Work, we welcome Mel Morris, founder and CEO of Corpora.AI, to explore how artificial intelligence is reshaping the way we research and consume information across industries and professions.

Mel, known for his pivotal role in the early success of Candy Crush creator King, has now set his sights on transforming how individuals, businesses, and institutions discover knowledge. With Corpora.AI, he has created a powerful research engine that processes two million documents per second and delivers comprehensive reports containing up to 500 cited sources per query. The platform ingests over 100 petabytes of open-source intelligence in real time, offering unparalleled speed, scale, and accuracy.

During our conversation, Mel explains why traditional search methods no longer scale for human users and how Corpora.AI addresses this by using real-time data ingestion, multilingual capabilities, and dynamic content summarization. We discuss how the platform is being used by academics, journalists, legal professionals, and even medical researchers to uncover deeper insights and verify claims quickly.

Mel also breaks down how the platform avoids common AI pitfalls such as outdated information, source ambiguity, and bias. Every report produced through Corpora.AI is transparent, traceable, and backed by robust citations, allowing users to make informed decisions with confidence. We also touch on the impact this could have on democratizing access to advanced research, especially in underserved regions.

With the future of work demanding faster, more credible, and more comprehensive access to information, can AI-powered research engines like Corpora.AI redefine how we learn and make decisions? Tune in to hear how this technology is setting a new benchmark for speed, transparency, and trust in research.